November 30, 2020 at 11:01PM Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17, 2020 to discuss Moderna’s emergency use authorization request for a COVID-19 vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/33xop7D

November 30, 2020 at 08:46PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Patient Affairs Staff (PAS) in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2P5qy5N

November 24, 2020 at 09:45PM Real-World Evidence

Real-world data (RWD) and real-world evidence (RWE) played an increasing role in health care decisions. The 21st Century Cures Act, passed in 2016, placed additional focus on the use of these types of data to support regulatory decision making.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QHG6v0

Friday, November 27, 2020

November 27, 2020 at 04:09PM Field Science - Laboratory Manual

The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and cour

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2zjOZEU

November 25, 2020 at 09:08PM 2020 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

This is the main page for the CBER 2020 Meeting Materials, Vaccines and Related Biological Products Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/31JuWdA

November 25, 2020 at 09:07PM Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement - 12/10/2020 - 12/10/2020

This is the CBER Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3l0KpOc

November 25, 2020 at 04:21PM Developing a Toolkit to Assess Efficacy of Ebola Vaccines and Therapeutics

MCMi regulatory science project to research issues that are key to understanding and predicting if—and how—vaccines and therapeutics to prevent and treat Ebola will show efficacy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NzF5El

Tuesday, November 24, 2020

November 24, 2020 at 10:53PM Safety and Effectiveness of Gene Therapy

A description of Andrew Byrnes' research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2NL0rgQ

November 24, 2020 at 09:45PM Impact of Immunity Induced by Viral and DNA Products

A description of Suzanne Epstein's research program and related publications.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2X5vJVl

November 24, 2020 at 08:20PM Application Submissions Guidances

This page lists Application Submissions Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JCweiX

Monday, November 23, 2020

November 23, 2020 at 11:17PM Learn About FDA Patient Engagement

Learn about the different ways that patients and caregivers are working with the FDA to have their voice included in medical product approvals and FDA policy.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35okko9

November 23, 2020 at 11:14PM FDA Patient Engagement Opportunities

A description of some of the opportunities for patients, caregivers and advocates to engage with the FDA.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32lI6PF

November 23, 2020 at 08:51PM FDA Voices on Policy

FDA Voices on Policy

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2wZLu61

November 23, 2020 at 06:01PM Why the United States-Mexico-Canada Agreement is Important to FDA

How the many provisions in the United States-Mexico-Canada Agreement affect FDA, advance public health and FDA’s regulatory approaches.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35ZdDsG

Friday, November 20, 2020

November 20, 2020 at 10:54PM Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccine Candidate

FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10, 2020 to discuss Pfizer and BioNTech’s emergency use authorization request for a COVID-19 vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3pP9Qpp

November 20, 2020 at 07:28PM Dr. Hahn’s Remarks to the Meeting of the Regulatory Affairs Professionals Society (RAPS) - 11/17/2020

Remarks by Stephen Hahn, MD, Commissioner of Food and Drugs, Meeting of the Regulatory Affairs Professionals Society (RAPS), Nov. 17, 2020, Washington, DC

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2HkSmzX

November 20, 2020 at 07:16PM Emergency Use Authorization for Vaccines Explained

FDA recognizes the gravity of the current public health emergency and the importance of facilitating availability, as soon as possible, of vaccines to prevent COVID-19 - vaccines that the public will trust and have confidence in receiving.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fgCcnX

November 20, 2020 at 06:54PM Vaccines

CBER regulates vaccine products. Vaccine information includes a listing of vaccines approved for marketing, questions about vaccines, vaccine safety and availability, and vaccine-related guidance documents, notices, and rules.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hTniF2

November 20, 2020 at 06:39PM Biologics License Applications (BLA) Process (CBER)

The Biologics License Application is used to request permission to introduce, or deliver a biologic product into interstate commerce.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3nUV1QL

November 20, 2020 at 04:51PM Vaccine Development – 101

Details the approval process for a vaccine product.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3kOQoWj

November 20, 2020 at 04:00PM Vibrant Health Care, Inc. - 608426 - 11/18/2020

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2HnVrPU

November 19, 2020 at 09:45PM Vaccine Notices, Proposed and Final Rules

List of vaccine notices, proposed and final rules

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Z9Nhiz

November 19, 2020 at 02:49PM Cross Labeling Oncology Drugs in Combination Regimens Guidance for Industry

Guidance for Industry - Clinical Medical

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2IW6Wy8

Wednesday, November 18, 2020

November 18, 2020 at 10:19PM TRG Rapid Inquiry Program (TRIP)

As a result of the July 2020 update to the FDA's guidance document, "Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue- Based Products: Minimal Manipulation and Homologous Use," FDA is extending the TRIP program through March 31, 2021.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35fzlpz

November 18, 2020 at 07:17PM Investigational New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted Without an IND

This guidance is intended to assist clinical investigators, sponsors, sponsor-investigators, and institutional review boards (IRBs) in determining whether research studies involving human subjects must be conducted under an investigational new drug application (IND).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2tvNm4C

November 18, 2020 at 05:28PM Getting Started with ICSR Submission to FDA’s electronic Vaccine Adverse Event Reporting System (eVAERS)

Follow the steps below for submitting ICSRs to the FDA's electronic Vaccine Adverse Event Reporting System (eVAERS).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3fusUmY

November 18, 2020 at 05:21PM CBER Vaccine ICSR Implementation

The CBER ICSR Implementation webpage was created to provide current information about CBER’s progress toward the adoption and implementation of the ISO/HL7 Individual Case Safety Report (ICSR) standard and the ICH E2B(R3) revised content specification to support electronic reporting to the Vaccine Adverse Event Reporting System (VAERS)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2IpXlNd

November 18, 2020 at 03:07PM Emergency Use Authorization for Vaccines to Prevent COVID-19

This is the Guidance for Industry for the Emergency Use Authorization for Vaccines to Prevent COVID-19. , COVID-19, Coronavirus Disease 2019, Vaccines , CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3iF3PqC

Tuesday, November 17, 2020

November 17, 2020 at 10:30PM Coronavirus (COVID-19) | CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3cPytLJ

November 17, 2020 at 10:03PM Health Fraud Scams

Learn how to spot health fraud and avoid it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UElHK2

Monday, November 16, 2020

November 17, 2020 at 12:02AM Coronavirus (COVID-19) Update: November 16, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KgyaR1

November 16, 2020 at 09:21PM Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2lznGQ9

November 16, 2020 at 09:21PM Investigational COVID-19 Convalescent Plasma

FDA is issuing this guidance to provide recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JRD7fD

November 16, 2020 at 02:51PM Electromagnetic Compatibility (EMC) of Medical Devices

FDA is issuing this guidance to recommend information that should be provided in a premarket submission to demonstrate electromagnetic compatibility.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32KLrHO

Friday, November 13, 2020

November 13, 2020 at 11:17PM Certificates of Confidentiality

This guidance describes FDA implementation of the revised provisions applicable to the request for, and issuance of, a Certificate of Confidentiality (CoC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2s23ABk

November 13, 2020 at 06:17PM 2020 Meeting Materials, Blood Products Advisory Committee

This is the main page for CBER's 2020 Meeting Materials, Blood Products Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2SnLJjb

November 13, 2020 at 03:40PM Vaccination Is the Best Protection Against Measles

Measles is not a harmless childhood disease. It's dangerous and can be life-threatening. Our most effective public health measure against measles is prevention with the measles vaccine.

via Consumer Updates RSS Feed https://ift.tt/36YwTnD

November 13, 2020 at 03:40PM Vaccination Is the Best Protection Against Measles

Measles is not a harmless childhood disease. It's dangerous and can be life-threatening. Our most effective public health measure against measles is prevention with the measles vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/36YwTnD

November 13, 2020 at 03:35PM Vaccines Protect Children From Harmful Infectious Diseases

If you have questions about vaccines, visit the FDA’s guide for parents and caregivers. It describes the routinely administered vaccines for children and provides answers to commonly asked questions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2vVIKpm

November 12, 2020 at 03:59PM Stakeholders in the highly competitive citrus market are pulling together at the international level to ensure the sustainability of the sector

The first edition of the Global Citrus Congress, co-organised by the World Citrus Organisation (WCO), CIRAD and Fruitnet Media International, was held in early November. More than 1 300 participants from 60 producing countries joined this entirely virtual event. Growth in supply is outstripping growth in demand on the international citrus market. Faced with the risk of saturation in certain parts of the market, stakeholders in the sector are working to achieve greater transparency between producers, as well as to promote their products to consumers.



via CIRAD - Actualités / News https://ift.tt/3f0jJM3

November 13, 2020 at 11:26AM Tribune | «Il faut institutionnaliser le concept “One Health” pour prévenir de nouvelles épidémies à l’échelle mondiale»

Un collectif de chercheurs, de médecins et de vétérinaires estime, dans une tribune au « Monde », que la gestion des épidémies émergentes nécessite une approche globale, baptisée « One Health », qui intègre différents secteurs et disciplines des santés humaine, animale, végétale et environnementale. Thierry Lefrançois, expert des approches intégrées et des réseaux de santé au Cirad, fait partie des signataires de la tribune.



via CIRAD - Actualités / News https://ift.tt/3f2tRnB

November 13, 2020 at 11:26AM Thierry Lefrançois : «Le lancement du Conseil d’experts de haut niveau Une seule santé constitue une étape essentielle pour la prévention des épidémies mondiales»

La création d’un Conseil d’experts de haut niveau One Health/Une seule santé vient d’être annoncée dans le cadre du Forum de la paix de Paris 2020. Ce conseil plébiscité par les scientifiques constitue un espoir majeur dans la prévention et la gestion des futures épidémies mondiales. Précisions avec Thierry Lefrançois, expert des approches intégrées et des réseaux de santé au Cirad.



via CIRAD - Actualités / News https://ift.tt/2Ulb4KG

November 12, 2020 at 05:39PM ASSET : vers des systèmes alimentaires et agricoles plus durables en Asie du Sud-Est

Les systèmes agricoles et alimentaires d’Asie du Sud-Est sont à la croisée des chemins, entre des modèles d’intensification conventionnels et des initiatives agroécologiques innovantes. Mis en œuvre par 27 partenaires au Cambodge, Laos, Myanmar et Vietnam, le projet ASSET explore, pendant 5 ans, la transition vers des systèmes plus durables, d’un point de vue social, environnemental et sanitaire.



via CIRAD - Actualités / News https://ift.tt/3lr5Dpz

November 12, 2020 at 03:59PM Les acteurs du marché très concurrentiel des agrumes s’organisent au niveau international pour assurer la durabilité de la filière

La première édition du Global Citrus Congress, co-organisé par la World Citrus Organisation (WCO), le Cirad et Fruitnet Media International, s’est tenue début novembre. Plus de 1300 participants en provenance de 60 pays producteurs ont rejoint l’évènement entièrement virtuel. Le marché international des agrumes connaît une croissance de son offre supérieure à la croissance de la demande. Face à un risque de saturation de certains pans du marché, les acteurs de la filière misent sur plus de transparence entre les producteurs, ainsi que sur la promotion de leurs produits auprès des consommateurs.



via CIRAD - Actualités / News https://ift.tt/3lruFEO

November 12, 2020 at 03:25PM Protect Your Family From Fraudulent Flu Products

Influenza season may bring out dishonest sellers hawking fraudulent products that claim to prevent, treat, or cure the flu. These unproven products, sold online and in stores, haven’t been evaluated by the FDA for safety and effectiveness.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2UmPOnK

November 12, 2020 at 03:25PM Protect Your Family From Fraudulent Flu Products

Influenza season may bring out dishonest sellers hawking fraudulent products that claim to prevent, treat, or cure the flu. These unproven products, sold online and in stores, haven’t been evaluated by the FDA for safety and effectiveness.

via Consumer Updates RSS Feed https://ift.tt/2UmPOnK

November 10, 2020 at 06:28PM Section 8000: General Information

This is the main page for CBER's SOPP Section 8000: General Information.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/322hgJI

November 10, 2020 at 05:44PM Clinical Guidances

This page lists Clinical Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2WeFbnh

November 10, 2020 at 01:30AM Tuberculin, Purified Protein Derivative - TUBERSOL

The product page for Tuberculin, Purified Protein Derivative - TUBERSOL containing the labeling and supporting documents

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YRaeGW

Monday, November 9, 2020

November 10, 2020 at 01:16AM Coronavirus (COVID-19) Update: November 9, 2020

Coronavirus (COVID-19) Update

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JJRTYS

November 09, 2020 at 04:42PM IXINITY

Indicated in adults and children ≥ 12 years of age with hemophilia B for control and prevention of bleeding episodes, and for perioperative management.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oY9e61

November 09, 2020 at 10:25AM Albedo Climate Change Mitigation

Un séminaire international organisé par le Cirad et l'institut de convergence CLAND, avec le soutien de l'initiative 4P1000 et de la Global Research Alliance on Agricultural Greenhouse Gases.



via CIRAD - Agenda / Events https://ift.tt/2U7QVYn

Friday, November 6, 2020

November 06, 2020 at 10:10PM Tissue & Advanced Therapies Research

This page is about Tissue & Advanced Therapies Research

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2B4RpYX

November 06, 2020 at 10:09PM Genome Editing and Advanced Manufacturing of Hematopoietic Stem Cell-Based Therapeutics

PI Webpage for Pankaj Kumar Mandal, PhD

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/38jfeLl

November 04, 2020 at 04:49PM Coronavirus Disease 2019 Testing Basics

Easy-to-understand information about the different types of coronavirus tests

via Consumer Updates RSS Feed https://ift.tt/38jGSHW

November 06, 2020 at 05:40PM Formation professionnelle | Le Cirad obtient la certification Qualiopi

Le Cirad devient l’un des premiers organismes français de recherche à bénéficier de la certification Qualiopi. Délivré par l’Afnor, ce label officiel atteste de la qualité des formations professionnelles dispensées.



via CIRAD - Actualités / News https://ift.tt/2Ic6Oe3

Thursday, November 5, 2020

November 05, 2020 at 09:51PM Biological Product Deviation Guidances & Rules

List of Biological Product Deviation Guidances & Rules

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2U2IMUz

November 05, 2020 at 06:34PM 3e Congrès international d'horticulture - IHC 2022

Organisé en partenariat avec le Cirad.



via CIRAD - Agenda / Events https://ift.tt/38lc21X

November 05, 2020 at 05:10PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Yc9luW

November 05, 2020 at 06:07PM Le genre en recherche - Évaluation et production des savoirs

Une journée de présentations et d’échanges sur les outils et méthodes pour réduire les biais de genre, organisée par le Cirad et l'ANR dans le cadre du projet européen Gender-SMART.



via CIRAD - Agenda / Events https://ift.tt/2TTP2OY

November 05, 2020 at 05:04PM FDA 101: How to Use the Consumer Complaint System and MedWatch

If you have a complaint about a product regulated by the Food and Drug Administration (FDA), the agency wants to hear about it.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Ox9tPq

November 05, 2020 at 04:13PM FDA Patient Engagement Overview*

FDA Patient Engagement Overview

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RdX1Fn

November 05, 2020 at 04:01PM Charter of the Cellular, Tissue and Gene Therapies Advisory Committee

This is the charter for CBER's Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TXo752

November 05, 2020 at 04:33PM FDA 101: How to Use the Consumer Complaint System and MedWatch

Advice on using FDA's Consumer Complaint System and MedWatch.

via Consumer Updates RSS Feed https://ift.tt/2Ox9tPq